• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 CRISPR/Cas9 生成 FLNA 基因敲除 hESC 系(WAe009-A-P),用于心脏瓣膜发育不良的建模。

Generation of a FLNA knockout hESC line (WAe009-A-P) to model cardiac valvular dysplasia using CRISPR/Cas9.

机构信息

Department of Cardiology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.

Department of Cardiology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.

出版信息

Stem Cell Res. 2023 Sep;71:103162. doi: 10.1016/j.scr.2023.103162. Epub 2023 Jul 1.

DOI:10.1016/j.scr.2023.103162
PMID:37429070
Abstract

The FLNA gene encodes the cytoskeletal protein filamin A which plays a key role in the structure and function of the cardiac valves. Truncating FLNA mutations are associated with cardiac valvular dysplasia. To further understand the exact role of FLNA in this disease, we have generated a human FLNA knockout cell line from H9 using CRISPR/Cas9 technology in this study. This cell line WAe009-A-P has a 2 bp deletion in the exon 2 of FLNA gene which resulted in a frameshift in the translation of FLNA and no FLNA protein was detected in this cell line. Moreover, WAe009-A-P also expressed pluripotency markers, had a normal female karyotype (46XX) and maintained the ability to differentiate into the three germ layers in vitro.

摘要

FLNA 基因编码细胞骨架蛋白细丝蛋白 A,它在心脏瓣膜的结构和功能中起着关键作用。截断的 FLNA 突变与心脏瓣膜发育不良有关。为了进一步了解 FLNA 在这种疾病中的确切作用,我们使用 CRISPR/Cas9 技术从 H9 中生成了人类 FLNA 敲除细胞系。该细胞系 WAe009-A-P 在 FLNA 基因的外显子 2 中存在 2 个碱基对缺失,导致 FLNA 翻译发生移码,并且在该细胞系中未检测到 FLNA 蛋白。此外,WAe009-A-P 还表达多能性标记物,具有正常的女性核型(46XX),并保持体外分化为三个胚层的能力。

相似文献

1
Generation of a FLNA knockout hESC line (WAe009-A-P) to model cardiac valvular dysplasia using CRISPR/Cas9.使用 CRISPR/Cas9 生成 FLNA 基因敲除 hESC 系(WAe009-A-P),用于心脏瓣膜发育不良的建模。
Stem Cell Res. 2023 Sep;71:103162. doi: 10.1016/j.scr.2023.103162. Epub 2023 Jul 1.
2
A CRISPR/Cas9 strategy for the generation of a FLNC knockout hESC line (WAe009-A-70) to model dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy.利用 CRISPR/Cas9 技术生成一个敲除 FLNC 的人胚胎干细胞系(WAe009-A-70),用于扩张型心肌病和致心律失常性右室心肌病的建模。
Stem Cell Res. 2021 Oct;56:102562. doi: 10.1016/j.scr.2021.102562. Epub 2021 Oct 7.
3
Establishment of a human TLR4 compound heterozygous knockout hESC line (WAe009-A-N) to model toll-like receptor 4 deficiency by CRISPR/Cas9 system.通过CRISPR/Cas9系统建立人TLR4复合杂合敲除人胚胎干细胞系(WAe009-A-N)以模拟Toll样受体4缺陷。
Stem Cell Res. 2023 Dec;73:103225. doi: 10.1016/j.scr.2023.103225. Epub 2023 Oct 29.
4
Generation of a TRPM8 knockout hESC line (WAe009-A-A) derived from H9 using CRISPR/Cas9.使用 CRISPR/Cas9 技术从 H9 细胞中生成 TRPM8 基因敲除 hESC 系(WAe009-A-A)。
Stem Cell Res. 2023 Mar;67:103040. doi: 10.1016/j.scr.2023.103040. Epub 2023 Feb 6.
5
Generation of a TAB2 knockout hESC line (WAe009-A-Z) derived from H9 using CRISPR/Cas9.利用 CRISPR/Cas9 技术从 H9 细胞中生成 TAB2 基因敲除 hESC 系(WAe009-A-Z)。
Stem Cell Res. 2024 Feb;74:103284. doi: 10.1016/j.scr.2023.103284. Epub 2023 Dec 16.
6
CRISPR/Cas9 mediated establishment of a human CSRP3 compound heterozygous knockout hESC line to model cardiomyopathy and heart failure.CRISPR/Cas9介导建立人CSRP3复合杂合敲除人胚胎干细胞系以模拟心肌病和心力衰竭。
Stem Cell Res. 2020 Dec;49:102077. doi: 10.1016/j.scr.2020.102077. Epub 2020 Nov 4.
7
Generation of a Junctophilin-2 homozygous knockout human embryonic stem cell line (WAe009-A-36) by an episomal vector-based CRISPR/Cas9 system.通过基于游离型载体的CRISPR/Cas9系统生成连接蛋白2纯合敲除的人胚胎干细胞系(WAe009-A-36)。
Stem Cell Res. 2020 Oct;48:101930. doi: 10.1016/j.scr.2020.101930. Epub 2020 Aug 3.
8
Generation of an S100B homozygous knockout pluripotent stem cell line (WAe009-A-94) by the CRISPR/Cas9 system.利用 CRISPR/Cas9 系统生成 S100B 纯合敲除多能干细胞系(WAe009-A-94)。
Stem Cell Res. 2022 Oct;64:102924. doi: 10.1016/j.scr.2022.102924. Epub 2022 Sep 20.
9
Generation of a TLR7 heterozygous knockout line (WAe009-A-18) from human embryonic stem cells using CRISPR/Cas9.利用CRISPR/Cas9从人胚胎干细胞中生成TLR7杂合敲除系(WAe009-A-18)。
Stem Cell Res. 2020 May;45:101735. doi: 10.1016/j.scr.2020.101735. Epub 2020 Mar 13.
10
Generating dHAND homozygous knockout human embryonic stem cell line (WAe009-A-59) by episomal vector-based CRISPR/Cas9 system.利用基于质粒载体的 CRISPR/Cas9 系统生成 dHAND 纯合敲除人胚胎干细胞系(WAe009-A-59)。
Stem Cell Res. 2021 Aug;55:102471. doi: 10.1016/j.scr.2021.102471. Epub 2021 Jul 20.